Search Results 641-650 of 24229 for In situ

  1. Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer - Mayo Clinic

    Exceptions include basal cell carcinoma of the skin or squamous cell carcinoma of the skin that has undergone potentially curative therapy or in situ cervical ...

  2. Cancer Clinical Trials - Medical Professionals

    ... in treating patients with HER2 expressing ductal carcinoma in situ. H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of ...

  3. A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma - Mayo Clinic

    ... in situ of the cervix or breast, adequately treated lentigo maligna melanoma, or localized prostate cancer. Adjuvant or maintenance therapy to reduce the ...

  4. Study to Evaluate the Efficacy and Safety of Lutathera in Patients with Grade 2 and Grade 3 Advanced GEP-NET - Mayo Clinic

    Other known co-existing malignancies except non-melanoma skin cancer and carcinoma in situ of the uterine cervix, unless definitively treated and proven no ...

  5. A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer - Mayo Clinic

    In this study enfortumab vedotin will be put into the bladder using a catheter. ... in situ (CIS) (with or without papillary disease) * Predominant histologic ...

  6. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    Further progression to PanIN2, carcinoma in situ (PanIN3) and pancreatic ductal adenocarcinoma occurs after acquisition of additional gene mutations in TP53 ( ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    excision, Breast cancer, Ductal carcinoma in situ, Fibroadenoma, Atypical hyperplasia of the breast, Male breast cancer, Breast cysts and lumps, BRCA gene ...

  8. Cyclophosphamide and Vaccine Therapy in Treating Patients with Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    Non-melanoma skin cancer or carcinoma-in-situ of the cervix; NOTE: If there is a history of prior malignancy, they must not be receiving other specific ...

  9. Surgery Clinical Trials - Medical Professionals

    ... in treating patients with HER2 expressing ductal carcinoma in situ. H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of ...

  10. A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens - Mayo Clinic

    ... in combination with standard multiple myeloma (MM) regimens in ... situ of the cervix, or breast, or other non-invasive lesion, that in the ...